Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 940 clinical trials in Hoofddorp, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
The NetherlandsStudy of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)
The NetherlandsStudy on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)
The NetherlandsStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
The NetherlandsStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
The NetherlandsStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
The NetherlandsStudy of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer
The NetherlandsStudy on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma
The NetherlandsStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
The NetherlandsStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
The NetherlandsThe NetherlandsStudy on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on various cancer types including breast cancer, bladder cancer, and melanoma. Studies are evaluating novel treatment combinations and maintenance therapies for improved patient outcomes.
Multiple trials are investigating innovative approaches for both solid tumors and blood cancers, with particular emphasis on targeted therapies.
Comprehensive studies examining treatments for various blood disorders, including chronic myeloid leukemia, myelofibrosis, and lymphomas. Focus on developing targeted therapies and combination treatments.
Research aims to improve treatment outcomes and quality of life for patients with blood disorders.
Research initiatives addressing obesity management and surgical conditions like appendicitis. Studies include weight management therapies and surgical technique improvements.
Trials focus on both therapeutic and surgical interventions for better patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
